MILLENNIUM MANAGEMENT LLC

Position in TCRX — TScan Therapeutics, Inc.

CIK 1273087 NEW YORK, NY

Position in TCRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,140,338

-$334,549 QoQ

Shares Held

1,163,611

-20.3% QoQ

Ownership

1.72%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 60 holders

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. TCRX ranks #244 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	468,410	$232,673,299
2	INSM	INSMED Inc	2,048,005	$218,358,293
3	APGE	Apogee Therapeutics, Inc.	1,491,404	$197,954,052
4	JAZZ	Jazz Pharmaceuticals plc	763,880	$184,072,163
5	ONC	BeOne Medicines Ltd.	543,323	$154,830,755
6	AXSM	Axsome Therapeutics, Inc.	556,088	$136,113,659
7	BMRN	Biomarin Pharmaceutical Inc	2,071,816	$118,549,311
8	REGN	Regeneron Pharmaceuticals, Inc.	165,120	$102,958,924

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,140,338	1,163,611	-20.3%	Shares	Sole	2026-08-14
2026-03-31	$1,474,887	1,460,285	+261.8%	Shares	Sole	2026-05-15
2025-12-31	$403,618	403,618	-13.4%	Shares	Sole	2026-02-17
2025-09-30	$848,276	466,086	-26.0%	Shares	Sole	2025-11-14
2025-06-30	$913,700	630,138	+172.6%	Shares	Sole	2025-08-14
2025-03-31	$319,021	231,175	+375.0%	Shares	Sole	2025-05-15
2024-09-30	$242,386	48,672	+74.5%	Shares	Sole	2024-11-14
2024-06-30	$163,150	27,889	-92.9%	Shares	Sole	2024-08-14
2024-03-31	$3,113,393	392,115	+295.7%	Shares	Sole	2024-05-15
2023-12-31	$577,648	99,082	+414.9%	Shares	Sole	2024-02-14
2022-12-31	$29,828	19,244	+56.8%	Shares	Sole	2023-02-14
2021-12-31	$55,242	12,276	-59.4%	Shares	Sole	2022-02-14
2021-09-30	$252,201	30,240	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.